Financhill
Back

Arrowhead Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46

ARWR
Arrowhead Pharmaceuticals, Inc.

Last Price:
$69.64
Seasonality Move:
17.03%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Arrowhead Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 68.52 Buy
20-day SMA: 66.69 Buy
50-day SMA: 51.31 Buy
200-day SMA: 27.38 Buy
8-day EMA: 68.87 Buy
20-day EMA: 64.65 Buy
50-day EMA: 54.27 Buy
200-day EMA: 34.35 Buy

Arrowhead Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.49 Buy
Relative Strength Index (14 RSI): 68.32 Buy
Chaikin Money Flow: 822440 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.43 - 71.63) Buy
Bollinger Bands (100): (24.09 - 55.37) Buy

Arrowhead Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Arrowhead Pharmaceuticals, Inc. Stock

Is Arrowhead Pharmaceuticals, Inc. Stock a Buy?

ARWR Technical Analysis vs Fundamental Analysis

Sell
46
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Sell

Is Arrowhead Pharmaceuticals, Inc. a Buy or a Sell?

Arrowhead Pharmaceuticals, Inc. Stock Info

Market Cap:
9.5B
Price in USD:
69.62
Share Volume:
896.7K

Arrowhead Pharmaceuticals, Inc. 52-Week Range

52-Week High:
72.36
52-Week Low:
9.57
Sell
46
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Sell

Arrowhead Pharmaceuticals, Inc. Share Price Forecast

Is Arrowhead Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Arrowhead Pharmaceuticals, Inc.

Is Arrowhead Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.

Technical Analysis of Arrowhead Pharmaceuticals, Inc.

Should I short Arrowhead Pharmaceuticals, Inc. stock?

* Arrowhead Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.